Retour
Également cotée sous
TLPPF
OTC
Fourchette du Jour
8,62 €
8,89 €
Fourchette 52 Semaines
6,28 €
20,00 €
Volume
234 479
Moyenne 50J / 200J
7,42 €
/
10,51 €
Clôture Précédente
9,13 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -278,1 | 0,3 |
| P/B | 4,8 | 2,9 |
| ROE % | -1,8 | 3,7 |
| Net Margin % | -0,9 | 3,8 |
| Rev Growth 5Y % | 254,9 | 10,0 |
| D/E | 1,3 | 0,2 |
Objectif de Cours des Analystes
Hold
17,00 €
+93.8%
P/E Prévisionnel
184,4
BPA Prévisionnel
0,05 €
Croissance BPA (est.)
+0,0%
CA Est.
1,4 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,07 €
1,01 € – 1,16 €
|
2,4 B | 3 |
| FY2029 |
0,79 €
0,75 € – 0,86 €
|
2 B | 3 |
| FY2028 |
0,39 €
-0,18 € – 0,78 €
|
1,8 B | 9 |
Points Clés
Revenue grew 254,93% annually over 5 years — strong growth
Earnings declined -121,40% over the past year
Negative free cash flow of -82,80M
Revenue growth is decelerating — 1Y growth trails 5Y average by 201,02%
Capital efficient — spends only 4,72% of revenue on capex
ROIC of 1,42% — low return on invested capital
Croissance
Revenue Growth (5Y)
254,93%
Revenue (1Y)53,91%
Earnings (1Y)-121,40%
FCF Growth (3Y)N/A
Qualité
Return on Equity
-1,80%
ROIC1,42%
Net Margin-0,89%
Op. Margin2,21%
Sécurité
Debt / Equity
1,26
Current Ratio1,43
Interest Coverage0,48
Valorisation
P/E Ratio
-278,06
P/B Ratio4,77
EV/EBITDA132,99
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 53,91% | Revenue Growth (3Y) | 54,88% |
| Earnings Growth (1Y) | -121,40% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 254,93% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,21B | Net Income (TTM) | -10,69M |
| ROE | -1,80% | ROA | -0,60% |
| Gross Margin | 53,11% | Operating Margin | 2,21% |
| Net Margin | -0,89% | Free Cash Flow (TTM) | -82,80M |
| ROIC | 1,42% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,26 | Current Ratio | 1,43 |
| Interest Coverage | 0,48 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -278,06 | P/B Ratio | 4,77 |
| P/S Ratio | 2,46 | PEG Ratio | 2,93 |
| EV/EBITDA | 132,99 | Dividend Yield | 0,00% |
| Market Cap | 2,97B | Enterprise Value | 3,54B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,21B | 783,21M | 502,55M | 160,10M | 7,60M |
| Net Income | -10,69M | 49,92M | 5,21M | -104,08M | -80,51M |
| EPS (Diluted) | -0,03 | 0,14 | 0,02 | -0,34 | -0,29 |
| Gross Profit | 640,23M | 509,68M | 314,39M | 29,34M | -29,77M |
| Operating Income | 26,64M | 82,13M | 51,89M | -91,93M | -81,25M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,77B | 1,52B | 398,30M | 260,59M | 109,81M |
| Total Liabilities | 1,15B | 948,22M | 249,39M | 175,35M | 106,17M |
| Shareholders' Equity | 622,27M | 568,21M | 148,91M | 80,01M | 2,16M |
| Total Debt | 784,47M | 581,45M | 17,45M | 10,45M | 2,54M |
| Cash & Equivalents | 212,53M | 710,35M | 123,24M | 116,33M | 22,04M |
| Current Assets | 494,79M | 918,56M | 224,85M | 173,23M | 47,54M |
| Current Liabilities | 347,00M | 330,91M | 157,41M | 85,56M | 37,98M |